AZN AstraZeneca PLC

$160.17▲ +0.33% Healthcare Other
After hours $156.10▼ -2.54% Sep 11, 7:58 PM ET
Volume 2.21M Avg Volume (10D) 3.18M
Key Metrics & Fundamentals
Market Cap
$248.41B
P/E Ratio
24.0
Div Yield
2.04%
52W Range
145.80 - 212.71
% vs 50 MA
-3.96%
% vs 200 MA
-12.71%
RSI-14
44.3
MACD Histogram
-0.1300
Beta (1Y vs SPY)
0.27
Free Cash Flow
-$240.00M
Gross Rev
$15.38B
Gross Profit
$12.86B
EBITDA
$5.16B
COGS
$2.52B
Operating Exp
$9.70B
Operating Income
$3.16B
EBIT
$3.16B
Pretax Income
$2.80B
Net Income
$2.51B
EPS (Diluted)
1.61
Price & Volume History
Loading chart…
Recent News
AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss — Executive ‘Disappointed,’ Reiterates Breast Cancer Focus
Stocktwits · Sep 11, 2026 10:11 PM
AstraZeneca Stock Trips On Unexpected Failure In Breast Cancer
Investor's Business Daily · Sep 11, 2026 9:01 PM
AstraZeneca Says Late-Stage Etcamah Breast-Cancer Trial Misses Main Goal
MT Newswires · Sep 11, 2026 8:58 PM
Jim Cramer Says He Is Not Going to Put His Money on AstraZeneca (AZN)
Insider Monkey · Sep 11, 2026 8:02 PM
Positive Lung Cancer Data Lifts the Case for Amgen and AstraZeneca
Insider Monkey · Sep 11, 2026 3:19 PM
MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE
Zacks · Sep 11, 2026 3:17 PM
Ipsen Weighs U.S. Manufacturing Investment
The Wall Street Journal · Sep 11, 2026 9:52 AM
Can a Tagrisso Combination Strengthen AstraZeneca’s Path to $80 Billion?
Insider Monkey · Sep 11, 2026 12:55 AM
AMGN, AZN Drug Combo Shows Survival Benefit in Lung Cancer Study
Zacks · Sep 10, 2026 3:56 PM
GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff
Zacks · Sep 10, 2026 3:35 PM
Financial Overview - Income Statement Quarterly

See AZN's money flow as a full page

Social Sentiment
Avg +0.60 · 7 posts
NewsEarningsTradePriceTarget$8000 call bet on AZN
r/wallstreetbets · Jul 27, 2026
Positive sentiment due to EPS beat, revenue growth, guidance increase, and cancer drug potential.
positive +0.80
NewsTrump Admin Doubles Down on Drug Pricing Reform and Onshoring Pharma Supply Chain Despite Industry Pushback
r/StockMarket · May 17, 2025
The post discusses the administration’s efforts to regulate ‘Big Pharma’, implying a potential negative impact on AZN (AstraZeneca).
negative +0.30
DDDiscussionEmerita Resources Gold and Silver at IBW Just the Gold and silver at IBW, approximately 1 million ozs gold and 50 million ozs silver
r/wallstreetbets · Mar 14, 2025
The combination of Aznalcóllar and IBW is seen as a highly valuable asset with a significant potential valuation.
positive +0.70
DiscussionNewsWhat is the purpose of an ADR Hedged ETF?
r/investing · Dec 28, 2024
The post focuses on understanding an ADR hedge ETF for AstraZeneca, demonstrating interest in the company's stock.
positive +0.60
TradeDiscussionDD$AZN options YOLO
r/wallstreetbets · Nov 23, 2024
The author expresses a bullish outlook on AZN, anticipating a significant price rebound.
positive +0.60
Page 1 of 2 (7 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙